Literature DB >> 19435799

Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.

Vera L Martins1, Jashmin J Vyas, Mei Chen, Karin Purdie, Charles A Mein, Andrew P South, Alan Storey, John A McGrath, Edel A O'Toole.   

Abstract

Type VII collagen (ColVII) is the main component of anchoring fibrils, attachment structures within the lamina densa of the basement membrane that are responsible for attachment of the epidermis to the dermis in skin. Mutations in the human ColVII gene, COL7A1, cause the severe inherited blistering disorder recessive dystrophic epidermolysis bullosa (RDEB) affecting skin and mucosae, associated with a greatly increased risk of skin cancer. In this study, we examined the effect of loss of ColVII on squamous cell carcinoma (SCC) tumourigenesis using RNAi in a 3D organotypic skin model. Our findings suggest that loss of ColVII promotes SCC migration and invasion as well as regulating cell differentiation with evidence for concomitant promotion of epithelial-mesenchymal transition (EMT). Immunostaining of RDEB skin and a tissue array of sporadic cutaneous SCCs confirmed that loss of ColVII correlates with decreased involucrin expression in vivo. Gene-expression-array data and immunostaining demonstrated that loss of ColVII increases expression of the chemokine ligand-receptor CXCL10-CXCR3 and downstream-associated PLC signalling, which might contribute to the increased metastatic potential of SCCs with reduced or absent ColVII expression. Together, these findings may explain the aggressive behaviour of SCCs in RDEB patients and may also be relevant to non-RDEB skin cancer, as well as other tumours from organs where ColVII is expressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435799      PMCID: PMC2684833          DOI: 10.1242/jcs.042895

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  65 in total

1.  Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis.

Authors:  C M Proby; K J Purdie; C J Sexton; P Purkis; H A Navsaria; J N Stables; I M Leigh
Journal:  Exp Dermatol       Date:  2000-04       Impact factor: 3.960

2.  A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.

Authors:  Anja Fritsch; Stefan Loeckermann; Johannes S Kern; Attila Braun; Michael R Bösl; Thorsten A Bley; Hauke Schumann; Dominik von Elverfeldt; Dominik Paul; Miriam Erlacher; Dirk Berens von Rautenfeld; Ingrid Hausser; Reinhard Fässler; Leena Bruckner-Tuderman
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

3.  Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.

Authors:  Tracy Wong; Luke Gammon; Lu Liu; Jemima E Mellerio; Patricia J C Dopping-Hepenstal; John Pacy; George Elia; Rosemary Jeffery; Irene M Leigh; Harshad Navsaria; John A McGrath
Journal:  J Invest Dermatol       Date:  2008-04-03       Impact factor: 8.551

4.  Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.

Authors:  A K Kivisaari; M Kallajoki; T Mirtti; J A McGrath; J W Bauer; F Weber; R Königová; D Sawamura; K C Sato-Matsumura; H Shimizu; M Csikós; K Sinemus; W Beckert; V-M Kähäri
Journal:  Br J Dermatol       Date:  2008-02-16       Impact factor: 9.302

5.  Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.

Authors:  Christine Bodemer; Sylvie Igondjo Tchen; Sabah Ghomrasseni; Sylvie Séguier; Frédérick Gaultier; Sylvie Fraitag; Yves de Prost; Gaston Godeau
Journal:  J Invest Dermatol       Date:  2003-08       Impact factor: 8.551

Review 6.  Context-dependent regulation of cutaneous immunological responses by TGFbeta1 and its role in skin carcinogenesis.

Authors:  Adam B Glick; Rolando Perez-Lorenzo; Javed Mohammed
Journal:  Carcinogenesis       Date:  2007-09-24       Impact factor: 4.944

7.  Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.

Authors:  Rubén A Bartolomé; Beatriz G Gálvez; Natividad Longo; Françoise Baleux; Goos N P Van Muijen; Paloma Sánchez-Mateos; Alicia G Arroyo; Joaquin Teixidó
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

8.  A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa.

Authors:  Matthias Titeux; Valérie Pendaries; Laure Tonasso; Audrey Décha; Christine Bodemer; Alain Hovnanian
Journal:  Hum Mutat       Date:  2008-02       Impact factor: 4.878

9.  Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.

Authors:  Jo-David Fine; Lorraine B Johnson; Madeline Weiner; Kuo-Ping Li; Chirayath Suchindran
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

10.  Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.

Authors:  Timothy A Chan; Sabine Glockner; Joo Mi Yi; Wei Chen; Leander Van Neste; Leslie Cope; James G Herman; Victor Velculescu; Kornel E Schuebel; Nita Ahuja; Stephen B Baylin
Journal:  PLoS Med       Date:  2008-05-27       Impact factor: 11.069

View more
  34 in total

1.  Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation.

Authors:  Vivi Andasari; Alf Gerisch; Georgios Lolas; Andrew P South; Mark A J Chaplain
Journal:  J Math Biol       Date:  2010-09-26       Impact factor: 2.259

2.  Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.

Authors:  Johannes S Kern; Stefan Loeckermann; Anja Fritsch; Ingrid Hausser; Wera Roth; Thomas M Magin; Claudia Mack; Marcel L Müller; Oliver Paul; Patrick Ruther; Leena Bruckner-Tuderman
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

Review 3.  Redox signaling at invasive microdomains in cancer cells.

Authors:  Begoña Díaz; Sara A Courtneidge
Journal:  Free Radic Biol Med       Date:  2011-09-29       Impact factor: 7.376

Review 4.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Authors:  Zhiwei Hu; Samira A Brooks; Valérian Dormoy; Chia-Wen Hsu; Hsue-Yin Hsu; Liang-Tzung Lin; Thierry Massfelder; W Kimryn Rathmell; Menghang Xia; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Kalan R Prudhomme; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Leroy Lowe; Lasse Jensen; William H Bisson; Nicole Kleinstreuer
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 5.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

6.  Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer.

Authors:  Andrei V Chernov; Alex Y Strongin
Journal:  Biomol Concepts       Date:  2011-06

7.  Collagen VII plays a dual role in wound healing.

Authors:  Alexander Nyström; Daniela Velati; Venugopal R Mittapalli; Anja Fritsch; Johannes S Kern; Leena Bruckner-Tuderman
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

8.  TAp63-Regulated miRNAs Suppress Cutaneous Squamous Cell Carcinoma through Inhibition of a Network of Cell-Cycle Genes.

Authors:  Andrew John Davis; Maksym Tsinkevich; Jason Rodencal; Hussein A Abbas; Xiao-Hua Su; Young-Jin Gi; Bin Fang; Kimal Rajapakshe; Cristian Coarfa; Preethi H Gunaratne; John M Koomen; Kenneth Y Tsai; Elsa R Flores
Journal:  Cancer Res       Date:  2020-03-10       Impact factor: 12.701

9.  Loss of collagen VII is associated with reduced transglutaminase 2 abundance and activity.

Authors:  Victoria Küttner; Claudia Mack; Christine Gretzmeier; Leena Bruckner-Tuderman; Jörn Dengjel
Journal:  J Invest Dermatol       Date:  2014-04-14       Impact factor: 8.551

Review 10.  Targeting tumor cell motility as a strategy against invasion and metastasis.

Authors:  Alan Wells; Jelena Grahovac; Sarah Wheeler; Bo Ma; Douglas Lauffenburger
Journal:  Trends Pharmacol Sci       Date:  2013-04-06       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.